This study aimed to measure and compare fecal lactoferrin levels in patients with IBD, IBS, and healthy controls to evaluate its diagnostic accuracy in differentiating IBD from IBS in a resource-limited setting. This evidence concerns the gene LTF and irritable bowel syndrome.